Comparable stake leader
Dragasac Ltd
SEC ownership of Celularity Inc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001752828.
Disclosed value leader
Dragasac Ltd
Comparable rows
41/50
Latest evidence
20 Apr 2026
- Public ticker
- CELU, CELUW on Nasdaq
- Parsed ownership sources
- 13D/G, 3/4/5, and 13F
- Largest SEC-reported holder
- Dragasac Ltd
- Latest 13D/G holder
- Dragasac Ltd
- Latest parsed ownership date
- 20 Apr 2026
- Issuer CIK
- 0001752828
- Issuer location
- Florham Park, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Celularity Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Dragasac Ltd
Disclosed value leader
Dragasac Ltd
Comparable rows
41/50
Latest evidence
20 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 41%
9 rows are not safely comparable across share classes.
13D/G row: Dragasac Ltd
Showing 1-8 of 50 holder rows.
Quick read
Dragasac Ltd leads the comparable SEC ownership view at 41%.
41 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Dragasac Ltd's linked filing trail.
Comparable ownership
Top 5
Dragasac Ltd
41%
Philip & Daniele Barach Family Trust
20%
BRISTOL MYERS SQUIBB CO
1.9%
Robert J. Hariri
12%
John R. Haines
0.13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Dragasac Ltd |
13D/G
3/4/5
Lim Kok Thay · 10%+ Owner
|
41%
|
$27,710,796
14,138,161 shares
|
+$8,232,000 | 24 Jul 2025 |
| Philip & Daniele Barach Family Trust |
13D/G
|
20%
|
—
7,558,665 shares
|
$0 | 20 Apr 2026 |
| BRISTOL MYERS SQUIBB CO |
13D/G
|
1.9%
|
$174,813
426,372 shares
|
$0 | 31 Dec 2024 |
| Robert J. Hariri |
3/4/5
Chief Executive Officer, Director
|
12%
|
$3,800,606
2,853,553 shares
mixed-class rows
|
— | 13 Apr 2026 |
| John R. Haines |
3/4/5
Senior Exec Vice President
|
0.13%
|
$42,829
30,179 shares
mixed-class rows
|
— | 13 Apr 2026 |
| Stephen Brigido |
3/4/5
Pres., Functional Regeneration
|
0.04%
|
$13,945
9,474 shares
mixed-class rows
|
— | 13 Apr 2026 |
| C V STARR & CO INC |
13F
Company
|
3.2%
|
$1,016,212
764,069 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
2.6%
|
$826,070
621,105 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 33 reporting-owner rows connected to Celularity Inc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
33
Largest Forms 3/4/5 holder
Lim Kok Thay
Net 12M change
$0
Latest report
20 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Lim Kok Thay | 10%+ Owner | $13,119,993 | Mixed | 24 Jul 2025 | ||
| Dragasac Ltd | 10%+ Owner | $7,485,632 | Mixed | 16 Jul 2021 | ||
| STARR INTERNATIONAL CO INC | 10%+ Owner | $3,805,066 | Mixed | 01 Mar 2022 | ||
| Robert J. Hariri | Chief Executive Officer, Director | $3,800,606 | Mixed | 13 Apr 2026 | ||
| Sorrento Therapeutics, Inc. | 10%+ Owner | $1,257,556 | Mixed | 29 Sep 2023 | ||
| Dean C. Kehler | Director | $1,247,311 | Mixed | 19 Dec 2024 | ||
| Diane L. Parks | Director | $577,223 | Mixed | 12 Jan 2026 | ||
| Adrian Kilcoyne | Chief Medical Officer | $487,051 | Mixed | 16 Feb 2024 | ||
| Peter Diamandis | Director | $437,506 | Mixed | 12 Jan 2026 | ||
| Berhad Genting | 10%+ Owner | $375,000 | Mixed | 20 Jun 2023 | ||
| Geoffrey Ling MD | Director | $284,188 | Mixed | 12 Jan 2026 | ||
| Richard J. Berman | Director | $277,080 | Mixed | 19 Dec 2024 | ||
| John Sculley | Director | $250,160 | Mixed | 14 Jun 2023 | ||
| Vincent LeVien | Director | $170,770 | Mixed | 12 Jan 2026 | ||
| Bradley Glover | Executive Vice President, Chief Operating Officer | $87,447 | Mixed | 13 Apr 2023 | ||
| Kyle Fletcher | Executive Vice President, General Counsel | $86,659 | Mixed | 13 Apr 2024 | ||
| Andrew C. von Eschenbach | Director | $83,680 | Mixed | 14 Jun 2023 | ||
| Robin L. Smith | Director | $58,780 | Mixed | 14 Jun 2023 | ||
| Marc Mazur | Director | $58,780 | Mixed | 14 Jun 2023 | ||
| John R. Haines | Senior Exec Vice President | $42,829 | Mixed | 13 Apr 2026 |
Recent insider transactions for Celularity Inc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Stephen Brigido | CELU | Class A Common Stock | Tax liability | -2.75% | -268 | 9,474 | 13 Apr 2026 | Direct | ||
| Stephen Brigido | CELU | Class A Common Stock | Options Exercise | 9.2% | 821 | 9,742 | 13 Apr 2026 | Direct | ||
| Stephen Brigido | CELU | Restricted Stock Units | Options Exercise | -100% | -821 | 0 | 13 Apr 2026 | Direct | ||
| John R. Haines | CELU | Class A Common Stock | Tax liability | -1.9% | -583 | 30,179 | 13 Apr 2026 | Direct | ||
| John R. Haines | CELU | Class A Common Stock | Options Exercise | 5.64% | 1,641 | 30,762 | 13 Apr 2026 | Direct | ||
| John R. Haines | CELU | Restricted Stock Units | Options Exercise | -100% | -1,641 | 0 | 13 Apr 2026 | Direct | ||
| Robert J. Hariri | CELU | Class A Common Stock | Tax liability | -0.04% | -1,182 | 2,853,553 | 13 Apr 2026 | Direct | ||
| Robert J. Hariri | CELU | Class A Common Stock | Options Exercise | 0.12% | 3,281 | 2,854,735 | 13 Apr 2026 | Direct | ||
| Robert J. Hariri | CELU | Restricted Stock Units | Options Exercise | -100% | -3,281 | 0 | 13 Apr 2026 | Direct | ||
| Diane L. Parks | CELU | Class A Common Stock | Award | 6.12% | 30,000 | 520,021 | 12 Jan 2026 | Direct | ||
| Peter Diamandis | CELU | Class A Common Stock | Award | 5.45% | 20,385 | 394,150 | 12 Jan 2026 | Direct | ||
| Geoffrey Ling MD | CELU | Class A Common Stock | Award | 8.12% | 19,231 | 256,026 | 12 Jan 2026 | Direct | ||
| Vincent LeVien | CELU | Class A Common Stock | Award | 23.1% | 28,847 | 153,847 | 12 Jan 2026 | Direct | ||
| Geoffrey Ling MD | CELU | Class A Common Stock | Award | 111.8% | 125,000 | 236,795 | 29 Dec 2025 | Direct | ||
| Geoffrey Ling MD | CELU | Stock Options | Award | 11.7% | 156,250 | 1,490,996 | 29 Dec 2025 | Direct | ||
| Vincent LeVien | CELU | Class A Common Stock | Award | 125,000 | 125,000 | 29 Dec 2025 | Direct | |||
| Vincent LeVien | CELU | Stock Options | Award | 156,250 | 156,250 | 29 Dec 2025 | Direct | |||
| Diane L. Parks | CELU | Class A Common Stock | Award | 34.2% | 125,000 | 490,021 | 29 Dec 2025 | Direct | ||
| Diane L. Parks | CELU | Stock Options | Award | 43.1% | 156,250 | 518,774 | 29 Dec 2025 | Direct | ||
| Peter Diamandis | CELU | Class A Common Stock | Award | 50.2% | 125,000 | 373,765 | 29 Dec 2025 | Direct | ||
| Peter Diamandis | CELU | Stock Options | Award | 43.1% | 156,250 | 518,774 | 29 Dec 2025 | Direct | ||
| Diane L. Parks | CELU | Class A Common Stock | Award | 22.6% | 67,416 | 365,021 | 19 Dec 2025 | Direct | ||
| Geoffrey Ling MD | CELU | Class A Common Stock | Award | 151.9% | 67,416 | 111,795 | 19 Dec 2025 | Direct | ||
| Peter Diamandis | CELU | Class A Common Stock | Award | 37.2% | 67,416 | 248,765 | 19 Dec 2025 | Direct | ||
| Diane L. Parks | CELU | Class A Common Stock | Award | 20.3% | 61,539 | 365,021 | 19 Nov 2025 | Direct | ||
| Vincent LeVien | CELU | Class A Common Stock | Award | 3,699 | 3,699 | 19 Nov 2025 | Direct | |||
| Geoffrey Ling MD | CELU | Class A Common Stock | Award | 65.8% | 44,379 | 111,795 | 19 Nov 2025 | Direct | ||
| Peter Diamandis | CELU | Class A Common Stock | Award | 23.3% | 47,042 | 248,765 | 19 Nov 2025 | Direct | ||
| Lim Kok Thay | CELU | Warrants (Right to Buy) | Other | 3,700,000 | 3,700,000 | 24 Jul 2025 | Direct | |||
| Lim Kok Thay | CELU | Warrants (Right to Buy) | Other | 2,450,000 | 1,350,000 | 24 Jul 2025 | By Resorts World Inc Pte. Ltd. | |||
| Lim Kok Thay | CELU | Warrants (Right to Buy) | Other | -100% | -1,950,000 | 0 | 24 Jul 2025 | By Resorts World Inc Pte. Ltd. | ||
| Vincent LeVien | CELU | Stock Options | Award | 186,336 | 186,336 | 05 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.